UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
This intro covers where to store your emergency fund in 2026, highlighting high-yield accounts, liquidity, and risk considerations to help you decide.
24,678 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Realty Income just announced a $1 billion joint venture with Apollo, expanding its real estate platform and preservin...
Market turbulence can unveil compelling buying opportunities. Learn why market crash: financial stocks deserve a plac...
A new wave of AI-enabled lending could be headed for auto loans. This article explains why upstart's auto loan push m...
Bitcoin surged to a 12-day high on news of a peace deal, driving a broad crypto market rally. ZEC and other altcoins ...
Velvet has surged 1,700% in a single month, driving it into crypto headlines. Traders weigh whether momentum will sus...
In a world of slim yields, five dividend stocks yielding more than 5% offer a chance for meaningful passive income. T...
A sweeping government push to secure rare earths could reshape the landscape for USA Rare Earth. This guide breaks do...
In several large markets, prices are softening while buyer interest remains steady. This article explains the forces ...
Bitcoin moved higher amid mixed signals: a large withdrawal of BTC from exchanges coinciding with rising futures shor...
Tech weakness pressured theStreet today, dragging the broader market even as select companies posted government contr...
Entering a competitive housing market? Don’t risk losing a deal. This guide walks you through 10 essential loan-ready...